Terumo Corp. (OTCMKTS:TRUMY) Short Interest Down 91.6% in April

Terumo Corp. (OTCMKTS:TRUMY) was the recipient of a significant drop in short interest during the month of April. As of April 30th, there was short interest totaling 30,823 shares, a drop of 91.6% from the April 15th total of 367,048 shares. Based on an average daily volume of 350,364 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the company’s shares are short sold.

Terumo Trading Down 1.3%

Shares of Terumo stock traded down $0.17 on Monday, reaching $12.39. The company had a trading volume of 471,423 shares, compared to its average volume of 209,291. The firm’s 50 day moving average price is $13.15 and its two-hundred day moving average price is $14.17. The firm has a market cap of $18.28 billion, a PE ratio of 21.66 and a beta of 0.62. Terumo has a 52-week low of $12.15 and a 52-week high of $20.12. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.89 and a current ratio of 1.51.

Terumo (OTCMKTS:TRUMY) last released its quarterly earnings results on Friday, February 13th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.01). The company had revenue of $1.94 billion during the quarter, compared to analysts’ expectations of $1.82 billion. Terumo had a net margin of 11.74% and a return on equity of 9.01%. Sell-side analysts predict that Terumo will post 0.58 earnings per share for the current fiscal year.

Analyst Ratings Changes

TRUMY has been the subject of several recent analyst reports. Nomura upgraded shares of Terumo to a “hold” rating in a research report on Tuesday, February 24th. Zacks Research upgraded shares of Terumo to a “hold” rating in a research report on Thursday, April 9th. Two research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Terumo has an average rating of “Hold”.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.